SonoVue联合超声辐照介导NET-1siRNA转染人肝癌细胞的研究的开题报告

精品文档---下载后可任意编辑SonoVue 联合超声辐照介导 NET-1siRNA 转染人肝癌细胞的讨论的开题报告摘要：肝癌是一种恶性肿瘤，是全球最常见的癌症之一。目前，肝癌的治疗手段主要有手术切除、放疗、化疗和介入治疗等。然而，这些治疗方法存在较严重的副作用和局限性，因此寻找新的治疗方法是当务之急。近年来，介导 RNA 干扰（RNAi）作为一种新型基因治疗方法逐渐被关注，在肝癌治疗中的应用也日益增多。但是，RNAi 在疗效和安全性方面仍需要进一步优化和改进。近年来，超声辐照技术作为一种介导 RNAi 的新方法逐渐成为讨论焦点。超声辐照可以使细胞膜通透性增加，同时也能够影响细胞内质膜的功能。因此，超声辐照可以辅助 RNAi 分子进入细胞，并提高其转染效率。此外，SonoVue 作为一种微泡造影剂，可以通过超声波激励形成空化现象，从而进一步提高 RNAi 转染效率。因此，本讨论将采纳超声辐照技术和 SonoVue 为载体，利用 RNAi技术特异性下调神经内分泌肿瘤源性肽（NET-1）的表达，在肝癌细胞中探究 RNAi 联合超声辐照介导的治疗效果和作用机制。同时，我们还将对 RNAi 联合超声辐照治疗肝癌的安全性进行评估，并探讨其在临床应用中的进展前景。关键词：RNA 干扰；超声辐照；SonoVue；NET-1；肝癌Abstract:Liver cancer is a malignant tumor and one of the most common cancers in the world. Currently, the treatment methods for liver cancer mainly include surgical resection, radiation therapy, chemotherapy, and interventional therapy, etc. However, these treatment methods have serious side effects and limitations, so finding new treatment methods is urgently needed. In recent years, RNA interference (RNAi) as a new gene therapy method has gradually attracted attention, and its application in liver cancer treatment has also increased. However, RNAi still needs to be further optimized and improved in terms of efficacy and safety.In recent years, ultrasound irradiation technology as a new method of RNA delivery has gradually become a research focus. Ultrasound irradiation can increase cell membrane 精品文档---下载后可任意编...